Few primary care practices are designed for the timely detection of Alzheimer's disease and related dementias. The limited ...

The past two decades have seen major advances in Alzheimer's disease research and clinical care, catalysed by the development of CSF and blood biomarkers and PET imaging that reliably detect amyloid β ...

Acumen Pharmaceuticals, Inc. ( ($ABOS) ) has released its Q3 earnings. Here is a breakdown of the information Acumen Pharmaceuticals, Inc.

Mayo Clinic researchers have developed a new tool that can estimate a person's risk of developing memory and thinking ...

HIGH blood pressure in children has emerged as a “substantial public health concern” with rates almost doubling since the ...

A study published Wednesday reports "significant" disparities in the risk of dementia for lower income and non-white ...

A team of researchers at the Federal University of ABC (UFABC) in Brazil has developed a new chemical compound with the ...

Researchers found that lecanemab, the Alzheimer’s drug designed to clear amyloid-β plaques, does not improve the brain’s waste clearance system in the short term.

A link has been discovered between how much money you make, and the risk of developing dementia later in life, researchers ...

Israel's president says authorities must take decisive action to stop “shocking and serious” Jewish settler violence against ...

Unfortunately there are no diets or supplements that are proven treatments for Alzheimer's disease, but there is increasing evidence that particular dietary measures could slow it's progress or delay ...